Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Older adult eyes | Image credit: michaelheim - stock.adobe.com
iAMD Progression Linked to Dysregulation of Complement Pathways

June 25th 2025

The hazard of the progression of intermediate age-related macular degeneration (iAMD) was higher in those whose complement pathways were not regulated.

Woman with eye condition | Image credit: New Africa - stock.adobe.com
GLP-1 Receptor Agonists Could Reduce Risk of Glaucoma in Type 2 Diabetes

June 18th 2025

Glaucoma in older individual | Image credit: Africa Studio - stock.adobe.com
Mental Health Scores Decreased in Patients Who Developed POAG

June 11th 2025

Eye | Image credit: mik_cz - stock.adobe.com
Corneal Curvature Measurements Significantly Affected by Dry Eye

June 3rd 2025

Dry eye | Image credit: Dragana Gordic - stock.adobe.com
Punctal Plugs Effective, Safe in Treating Moderate, Severe Dry Eye Disease

May 28th 2025

Continuing Medical Education
View All
July 1st 2025

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology
July 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 1st 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
July 1st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
July 1st 2025

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry
July 1st 2025

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry

More News

Evolution of Access to Treatment for Wet AMD/DME Therapies
March 23rd 2023

Evolution of Access to Treatment for Wet AMD/DME Therapies

Dr Sheth discusses the evolution of access to treatment for AMD/DME over the past few years and initiatives to expand treatment access.
Wet AMD Resource Utilization Impacted by Medication Duration of Action
March 23rd 2023

Wet AMD Resource Utilization Impacted by Medication Duration of Action

Joseph Coney, MD, FASRS, FACS, discusses switching anti-VEGF agents in the treatment of wet AMD and what payers should consider when switching anti-VEGF therapies.
Eye
March 21st 2023

Estimates of Diabetic Retinopathy Incidence, Progression Lower Than Previously Reported in American Indians

Julia Bonavitacola
American Indians and Alaska Native individuals had lower estimates of incidence of diabetic retinopathy than had been reported.
Utilization Management Strategies in Treatment of Wet AMD and DME
March 16th 2023

Utilization Management Strategies in Treatment of Wet AMD and DME

Veeral Sheth, MD, MBA, FACS, Joseph Coney, MD, FASRS, FACS, and Caesar Luo, MD, FASRS, FACS discuss their experience with utilization management strategies.
Treatment Barriers Facing Patients With DME and Wet AMD
March 16th 2023

Treatment Barriers Facing Patients With DME and Wet AMD

Caesar Luo, MD, FASRS, FACS discusses the biggest barriers for patients with wet AMD and DME to receiving optimal treatment and his strategies to overcome these barriers.
Woman with eye drops
March 15th 2023

Treatments for DED Associated With MGD Require Future Evaluation, Development

Julia Bonavitacola
A systematic review found that there were currently a limited number of clinical trials evaluating treatment for dry eye disease (DED) that is associated with meibomian gland dysfunction (MGD).
Woman's eyes
March 9th 2023

Faster Rates of GCIPL, cpRNFL Thinning Associated With Higher Risks of Glaucoma

Julia Bonavitacola
Ganglion cell/inner plexiform layer (GCIPL) and circumpapillary retinal nerve fiber layer (cpRNFL) thinning were both associated with a higher risk of developing perimetric glaucoma.
Diagnostic Imaging Impacting DME and Wet AMD Treatment Landscape
March 9th 2023

Diagnostic Imaging Impacting DME and Wet AMD Treatment Landscape

A panel of medical experts discuss diagnostic imaging surrounding DME and wet AMD.
Novel Treatment Mechanisms for Patients with DME and Wet AMD
March 9th 2023

Novel Treatment Mechanisms for Patients with DME and Wet AMD

Drs Coney, Luo, and Sheth discuss potential novel treatment mechanisms or options that we could see in the future with wet AMD and DME.
Screenshot of Eleonora Lad, MD, PhD, smiling during a Zoom video interview
March 5th 2023

Pegcetacoplan Approval a “Dream Come True” for Patients With Geographic Atrophy, Says Dr Eleonora Lad

Laura Joszt, MA
Pegcetacoplan was approved by the FDA to treat geographic atrophy (GA), providing a treatment option for patients who previously had none, explained Eleonora Lad, MD, PhD, associate professor of ophthalmology, Duke University.
Clinical Considerations for Retreatment in Failed Anti-VEGF Therapy
March 2nd 2023

Clinical Considerations for Retreatment in Failed Anti-VEGF Therapy

Veeral Sheth, MD, MBA, FACS discusses re-treatment in patients with wet AMD who have previously failed an anti-VEGF therapy.
Faricimab Approved Label Dosing Interval
March 2nd 2023

Faricimab Approved Label Dosing Interval

Dr Coney expands on the role and impact of approved label dosing of faricimab.
Eye with technology overlay
March 2nd 2023

Amsler Grid Test Not Recommended for Early AMD Detection

Julia Bonavitacola
A recent review found that the performance of the Amsler grid test was not at a level that was recommended for detecting early or dry age-related macular degeneration (AMD).
Baby in mother's arms
March 1st 2023

Cataract Surgery in Children Commonly Led to Glaucoma-Related Adverse Events

Julia Bonavitacola
The Pediatric Eye Disease Investigator Group collected data on children who had lensectomy prior to age 13 years in a 5-year span.
Richard Allen, MD, PhD, FACS
February 24th 2023

Dr Richard Allen Discusses Oculoplastic Surgery in Pediatric Patients

Skylar Jeremias Julia Bonavitacola
Richard Allen, MD, PhD, FACS, professor at Baylor College of Medicine, reviewed the challenges of oculoplastic surgery in pediatric patients.
Faricimab: Mechanism of Action, Payers’ Perspective, and Real-World Experience
February 23rd 2023

Faricimab: Mechanism of Action, Payers’ Perspective, and Real-World Experience

Key opinion leaders discuss faricimab, its impact on the treatment landscape for wet AMD/DME, and what payers should look for when considering formulary positioning or utilization-management strategies.
Variability of Frequency Dosing for Anti-VEGF Agents in the Treatment of Wet AMD
February 23rd 2023

Variability of Frequency Dosing for Anti-VEGF Agents in the Treatment of Wet AMD

Dr Coney discusses the variability of frequency dosing with anti-VEGF therapy in patients with wet AMD and DME, and Dr Sheth expands on Ang-2 and its contribution to the development of vascular instability in wet AMD.
Older woman's eye
February 22nd 2023

Visual Impairment Associated With Negative Effects on Older Adults With Dementia

Julia Bonavitacola
A review found that visual impairment is common in older adults with dementia and associated with negative effects.
Red FDA Approved stamp
February 17th 2023

FDA Approves First Treatment for Geographic Atrophy

Laura Joszt, MA
Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients.
Anti-VEGF and Gene Therapy Impacting Wet AMD and DME Treatment Landscapes
February 16th 2023

Anti-VEGF and Gene Therapy Impacting Wet AMD and DME Treatment Landscapes

Dr Sheth discusses his insights on anti-VEGF therapy that he has noticed in the treatment of wet AMD over the last decade, and Caesar Luo, MD, FASRS, FACS shares his insight on new treatment options and their impact on patient access and cost considerations.
Important Considerations Regarding Treatment Selection for Wet AMD and DME Patient Populations
February 16th 2023

Important Considerations Regarding Treatment Selection for Wet AMD and DME Patient Populations

Dr Coney and Veeral Sheth, MD, MBA, FACS, FASRS, discuss treatment selection, treatment goals, and unmet needs for patients diagnosed with wet AMD and DME.
Woman using eyedrops
February 14th 2023

Atropine Eyedrops Associated With Lower Incidence of Myopia, Myopic Shift

Julia Bonavitacola
A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo.
Michael Cohen, MD, FAAO
February 9th 2023

Dr Michael Cohen Discusses Accessibility of Future Gene Therapies

Skylar Jeremias Julia Bonavitacola
Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.
How Do the Patient Populations Differ for Wet AMD vs DME?
February 9th 2023

How Do the Patient Populations Differ for Wet AMD vs DME?

Joseph Coney, MD, FASRS, FACS, discusses the difference between population groups in age-related macular degeneration (AMD) and diabetic macular edema (DME)
Overview of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
February 9th 2023

Overview of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

Jim Kenney, RPh, MBA, opens a discussion surrounding wet age-related macular degeneration (AMD) and diabetic macular edema (DME).
Eye
February 6th 2023

Disparities in Pediatric Ophthalmology Have Increased

Julia Bonavitacola
Disparities in access to pediatric ophthalmological care is associated with lower socioeconomic status.
Eye
January 30th 2023

Vision Impairment Found in More Than a Quarter of Older US Adults

Julia Bonavitacola
A recent study has found that the prevalence of vision impairment in US adults 71 years and older was higher in 2021 compared with prior estimates.
Dr Michael Chiang Speaks About the NEI's Involvement in AMD, Addressing Health Disparities
January 26th 2023

Dr Michael Chiang Speaks About the NEI's Involvement in AMD, Addressing Health Disparities

Skylar Jeremias Julia Bonavitacola
Michael Chiang, MD, director of the National Eye Institute, spoke about efforts to address age-related macular degeneration (AMD) as well as health disparities in clinical trials and access to treatment.
Close up of eye
January 23rd 2023

Increased Incident CVD Risk Associated With RNFL Thinning

Julia Bonavitacola
Retinal nerve fiber layer (RNFL) thickness has been independently associated with incident cardiovascular disease risks in a new analysis that utilized data from 2 international databases.
Eye of an older woman
January 16th 2023

Hydroxychloroquine Dose Associated With Greater Risk of Incident Retinopathy

Julia Bonavitacola
Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.
<12345678910
...
19>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo